Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

51,258 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Advantage of yttrium-90-labeled over iodine-131-labeled monoclonal antibodies in the treatment of a human lung carcinoma xenograft.
Stein R, Chen S, Haim S, Goldenberg DM. Stein R, et al. Cancer. 1997 Dec 15;80(12 Suppl):2636-41. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2636::aid-cncr39>3.3.co;2-n. Cancer. 1997. PMID: 9406718
Successful therapy of a human lung cancer xenograft using MAb RS7 labeled with residualizing radioiodine.
Stein R, Govindan SV, Chen S, Reed L, Spiegelman H, Griffiths GL, Hansen HJ, Goldenberg DM. Stein R, et al. Crit Rev Oncol Hematol. 2001 Jul-Aug;39(1-2):173-80. doi: 10.1016/s1040-8428(01)00106-8. Crit Rev Oncol Hematol. 2001. PMID: 11418314
Radioimmunotherapy of a human lung cancer xenograft with monoclonal antibody RS7: evaluation of (177)Lu and comparison of its efficacy with that of (90)Y and residualizing (131)I.
Stein R, Govindan SV, Chen S, Reed L, Richel H, Griffiths GL, Hansen HJ, Goldenberg DM. Stein R, et al. J Nucl Med. 2001 Jun;42(6):967-74. J Nucl Med. 2001. PMID: 11390564
Phase I and pharmacologic study of 7- and 21-day continuous etoposide infusion in patients with advanced cancer.
Robert F, Chen S, Miller AA, Lee BC, Molthrop DC, Wheeler RH. Robert F, et al. Cancer Chemother Pharmacol. 1996;38(5):459-65. doi: 10.1007/s002800050511. Cancer Chemother Pharmacol. 1996. PMID: 8765440 Clinical Trial.
[Treatment of advanced metastatic breast cancer with exemestane, a multicenter randomized controlled study of 195 cases].
Wang HQ, Ren CC, Feng WJ, Lin MB, Xiong YQ, Huang P, Zhao WH, Hao XS, Chen SB, Yan Z. Wang HQ, et al. Zhonghua Yi Xue Za Zhi. 2003 Feb 10;83(3):188-90. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12812657 Clinical Trial. Chinese.
Concomitant cisplatin/5-FU infusion and radiotherapy in advanced head and neck cancer: 8-year analysis of results.
Taylor SG 4th, Murthy AK, Griem KL, Recine DC, Kiel K, Blendowski C, Hurst PB, Showel JT, Hutchinson JC Jr, Campanella RS, Chen S, Caldarelli DD. Taylor SG 4th, et al. Head Neck. 1997 Dec;19(8):684-91. doi: 10.1002/(sici)1097-0347(199712)19:8<684::aid-hed6>3.0.co;2-1. Head Neck. 1997. PMID: 9406747
BACKGROUND: The purpose of this study was to analyze long-term follow-up of a single institution's experience with a regimen of concomitant cisplatin/fluorouracil (5-FU) infusion and radiation given every other week. ...
BACKGROUND: The purpose of this study was to analyze long-term follow-up of a single institution's experience with a regimen of conco …
Phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficiency virus infection.
Husson RN, Chung Y, Mordenti J, Butler KM, Chen S, Duliege AM, Brouwers P, Jarosinski P, Mueller BU, Ammann A, et al. Husson RN, et al. J Pediatr. 1992 Oct;121(4):627-33. doi: 10.1016/s0022-3476(05)81161-8. J Pediatr. 1992. PMID: 1357124 Clinical Trial.
Resting-state functional magnetic resonance imaging with independent component analysis for presurgical seizure onset zone localization: A systematic review and meta-analysis.
Chakraborty AR, Almeida NC, Prather KY, O'Neal CM, Wells AA, Chen S, Conner AK. Chakraborty AR, et al. Among authors: chen s. Epilepsia. 2020 Aug 8. doi: 10.1111/epi.16637. Online ahead of print. Epilepsia. 2020. PMID: 32770853
51,258 results
Jump to page
Feedback